Circulating miRNAs as Predictor Markers for Activation of Hepatic Stellate Cells and Progression of HCV-Induced Liver Fibrosis
Keywords:
liver fibrosis, microRNAs, chronic hepatitis C, hepatic stellate cellAbstract
Introduction: Liver fibrosis is the excessive accumulation of extracellular matrix that occurs by activation of hepatic stellate cells (HSCs), which has been identified as the major driver of liver fibrosis. Several studies confirmed that miRNAs have regulatory effects on the activation of HSCs by affecting the signaling pathways. The aim of this study was to develop non-invasive diagnostic markers by measuring different circulating miRNAs in serum as predictor markers for early diagnosis of liver fibrosis and its progression.
Methods: In this case-control study, we enrolled 66 subjects with chronic hepatitis C (CHC) with early stage of fibrosis and 65 subjects with CHC with late-stage fibrosis. Also, 40 subjects were included as normal controls. The six main miRNAs, i.e., miR-138, miR-140, miR-143, miR-325, miR-328, and miR-349, were measured using the reverse transcription-polymerase chain reaction.
Results: In the cases of CHC both with early and late stage of fibrosis, the circulating levels of the six main miRNAs were significantly higher than the levels in the control group. ROC analysis indicated that the sensitivity and specificity of miR-138 were 89.3% and 71.43%, respectively, in the early stage of fibrosis. In the late stage, the sensitivity and specificity of miR-138 were 89.3 and 93.02%, respectively, whereas, for miR-143, they were 75.0 and 88.4%, respectively.
Conclusions: Circulating miR-138 could serve as a non-invasive biomarker for the detection of early fibrosis. Also, miR-138 and miR-143 could be specific biomarkers for indicating the late stage of liver fibrosis.
References
Kown Y, Ray RB, Ray R., “Hepatitis C virus infection: establishment of chronicity and liver disease
progression,” EXCLI Journal. 2014; 13: 977-96.
Kumar V and Mahato R. Delivery and targeting of miRNAs for treating liver fibrosis. Pharmaceutical
Research, 2015; 32: 341-61. doi: 10.1007/s11095-014-1497-x, PMid: 25186440
Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of micro
RNAs. Genome Res. 2009; 19: 92-105. doi: 10.1101/gr.082701.108, PMid: 18955434, PMCid:
PMC2612969
He Y, Huang C, Zhang SP, Sun X, Long XR, Li J. The potential of micro RNAs in liver fibrosis. Cellular
Signaling 2012; 24: 2268-72. doi: 10.1016/j.cellsig.2012.07.023, PMid: 22884954
Roy S, Benz F, Luedde T and Roderburg C. The role of miRNAs in the regulation of inflammatory
processes during hepatofibrogenesis. Hepatobiliary 2015; 4(1): 24-33.
Wang B, Li W, Guo K, Xiao Y, Wang Y, Fan J. MiR-181b promotes hepatic stellate cells proliferation by
targeting p 27 and is elevated in the serum of cirrhosis patients. Biochemical and Biophysiol research
Communications 2012; 421: 4-8. doi: 10.1016/j.bbrc.2012.03.025, PMid: 22446332
Chen C, Zhang Y, Zhang L, Weakley SM, Yao Q. Micro RNA-196 critical roles and clinical applications
in development and cancer, J Cell Mol Med. 2011;15: 14-23. doi: 10.1111/j.1582-4934.2010.01219.x,
PMid: 21091634, PMCid: PMC3276076
Guo CJ, Pan Q, Cheng T, Jiang B, Chen GY and Li DG. Changes in miRNAs associated with hepatic
stellate cell activation status identify signaling pathways. FEBS Journal 2009; 276: 5163-73. doi:
1111/j.1742-4658.2009.07213.x, PMid: 19674103
Roberts AP, Lewis AP, Jopling CL. The role of microRNAs in viral infection. Prog Mol Biol Transl Sci
; 102: 101-39. doi: 10.1016/B978-0-12-415795-8.00002-7, PMid: 21846570
Mendias CL, Gumucio JP and Lynch EB. Mechanical loading and TGF-β change the expression of
multiple miRNAs in tendon fibroblasts. J Appl Physiol 2012; 113(1): 56-62. doi:
1152/japplphysiol.00301.2012, PMid: 22539168, PMCid: PMC3404830
Shrivastava S, Mukherjee A & Ray RB. Hepatitis C virus infection, micro RNA and liver disease
progession. World J Hepatol 2013; 5 (9): 479-88. doi: 10.4254/wjh.v5.i9.479, PMid: 24073299, PMCid:
PMC3782685
Murakami Y, Toyoda H, Tanaka M, Kuroda M, Harado Y, Matsuda F, et al. The progression of liver
fibrosis is related with overexpression of the miR-199 and 200 families. PLOS One 2011; 6: 16081-95. doi:
1371/journal.pone.0016081, PMid: 21283674, PMCid: PMC3025920
Huang J, Yu X, Fries JWU, Zhang L and Odenthal M. microRNA function in the profibrogenic interplay
upon liver disease. Int J Mol Sci 2014; 15(6); 9360-71. doi: 10.3390/ijms15069360, PMid: 24871365,
PMCid: PMC4100099
Au JS, Pockros PJ. Novel therapeutic approaches for hepatitis C. Clin Pharmacol Ther 2014; 95: 78-88.
doi: 10.1038/clpt.2013.206, PMid: 24126682
Veerapu NS, Park SH, Tully DC, Allen TM, Rehermann B. Trace amounts of sporadically reappearing
HCV RNA can cause infection. J Clin Invest 2014; 124: 3469-78. doi: 10.1172/JCI73104, PMid:
, PMCid: PMC4109550
Chang C, Lin C, Hsieh W, Lai H, Tsai C and Cheng Y. microRNA expression profiling in PBMCs: A
potential diagnostic biomarker of chronic hepatitis C. Disease markers 2014; 1-9. doi:
1155/2014/367157, PMid: 25505813, PMCid: PMC4255053
Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc
; 3: 1101–8. doi: 10.1038/nprot.2008.73
Brase JC, Wuttig D, Kuner R, Sultmann H. Serum micro RNAs as non-invasive biomarkers for cancer. Mol
cancer, 2010; 9: 306-11. doi: 10.1186/1476-4598-9-306, PMid: 21110877, PMCid: PMC3002336
Allergra A, Alonic A, Campo S, Penna G, Petrungaro A, et al. Circulating micro RNAs; new biomarkers in
diagnosis, prognosis and treatment of cancer (review). Int J Oncol 2012; 41: 1897-1912.
Hernandez-Gea V. and Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol 2011; 6: 425-56. doi:
1146/annurev-pathol-011110-130246, PMid: 21073339
Schrum LW and Lakner AM. Treatment of fibrosis using microRNA 19b. U.S. patent 2014; 8: 1-17.
Ji J, Zhang J, Huang G, Qian J, Wang X, Mei S. Over-expressed microRNA-27a and -27b influence that
accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett 2009; 583: 759-66.
doi: 10.1016/j.febslet.2009.01.034, PMid: 19185571
Li J, Ghazwani M, Zhang Y. miR-122 regulates collagen production via targeting hepatic stellate cell
migration and activation. Exp Cell Res 2013; 317: 1714-25. doi: 10.3389/fimmu.2012.00116, PMid:
, PMCid: PMC3349963
Liu Y, Munker S, Mullenbach R. IL-13 signaling in liver fibrogenesis. Front Immunol 2012; 3: 116-8.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
